Overall, the erythroid lineage-associated antigens CD36, CD105, and CD71 have a reduced expression on the AML blasts compared to normal myHPCs (Figures 1–5D, 6B and Supplementary Figure 5 row T3). This evidence concerns the gene TFRC and acute myeloid leukemia.